Browsing by Subject "Alzheimer’s disease"
Now showing items 1-20 of 23
-
An ambient assisted living system for Alzheimer’s patients
(Brac University, 2022-09)Alzheimer’s is a brain disorder that gradually deteriorates the brain functions of the patients. As the disease progresses, victims start to lose their memory, thinking ability, eventually rendering them unable to perform ... -
Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
(Brac University, 2022-03)Alzheimer's disease is a fatal illness that primarily affects older generations; its pathology pathways include beta-amyloid, tau protein, and activated microglia, destruction of synapse and no disease-modifying medication ... -
Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
(Brac University, 2022-04)A decade has passed since no new Alzheimer's disease (AD) therapies were approved, even though it is the leading motive of dementia in the modern era. The community of patients with AD leads to expansion. Anxiety, anger, ... -
Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
(Brac University, 2023-02)Alzheimer's disease (AD) is a progressive neurological condition marked by memory or cognitive impairment, behavioral changes, visuospatial difficulties, decreased propensity to carry out day to day living tasks, and ... -
Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
(Brac University, 2021-09)Alzheimer’s Disease (AD) is a neurological condition where the decline of brain cells causes acute memory loss and severe loss in cognitive functionalities. Various Neuroimaging techniques have been developed to diagnose ... -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
(Brac University, 2022-10-30)Rivastigmine is an anti-cholinesterase agent, used to treat mild to moderate dementia of Alzheimer’s disease (AD). Its efficacy and tolerability increase the treatment compliance. This study focused on determining the ... -
Emerging therapies of Alzheimer’s disease: a comprehensive review
(Brac University, 2022-11)Alzheimer’s disease is a complex, debilitating neurodegenerative disorder, with a rapidly increasing worldwide prevalence. Despite decades of intense research, therapeutics for Alzheimer's disease are still limited to ... -
Epigenetic dysregulation in neurodegenerative diseases and potential treatment
(Brac University, 2022-04)Epigenetics holds significant relevance in the contemporary neuroscience and has been associated with the pathogenesis of different neurodegenerative disorders. Epigenetic modifications including DNA methylation and histone ... -
Glymphatic system: a pathway for managing endogenous metabolites in CNS
(Brac University, 2017-11)Glymphatic pathway is one of the recent discoveries of neuro pharmacology which is a brainwide paravascular system to exchange cerebrospinal fluid (CSF) and interstitial fluid. This system is associated with the clearance ... -
Investigating the link between Cardiovascular diseases and neurodegenerative disorders
(Brac University, 2022-11)Neurodegenerative (ND) disturbances (such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and spinal cord injury) are a notable public health concern across the world, and they are growing more ... -
Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
(Brac University, 2022-04)Purpose: Alzheimer's disease (AD) is a multifactorial neurodegenerative brain disorder that affects approximately 5.3 million people in the United States, including nearly half of the population aged 85 and up. It has ... -
Marine compounds in the treatment of Alzheimer’s disease
(Brac University, 2022-03)Brain shrinkage and cell death occurs due to Alzheimer's disease, a degenerative neurologic illness. Memory loss, social and behavioral deterioration, and the inability to operate independently are all symptoms of Alzheimer's ... -
Mini-mental state examination in hospitalized post COVID-19 patient to identify the risk of AlzheiMer`s development
(Brac University, 2023-02)SARS Covid-19 has affected 6 million people in 2020 to 2022. The primary difficulty the patient faces respiratory difficulty. But the virus affects several peripheral systems as well. Central nervous system is one of the ... -
A pharmacovigilance study of gender differences in rhabdomyolysis risk among donepezil users with alzheimer`s disease
(Brac University, 2023-10)Alzheimer’s disease is the most common disease for older patients marked by symptoms of dementia. This study was conducted for the pharmacovigilance investigation of donepezil related to adverse event rhabdomyolysis among ... -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
(Brac University, 2023-02)Alzheimer’s disease is an age-related neurodegenerative disease that effects the cognitive ability of a person. The cholinesterase inhibitor “donepezil” is used to treat Alzheimer's disease. Donepezil has shown the greatest ... -
A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
(Brac University, 2023-02)Alzheimer's Disease (AD) is a complex and common neurological disorder and dementia's leading cause. Memantine works to treat moderate to severe AD. This study focused on Food and Drug Administration Adverse Event Reporting ... -
Potential treatments for epigenetic dysregulation in neurological diseases
(Brac University, 2023-02)Epigenetics is of great importance to modern neuroscience because of its link to the etiology of certain neurodegenerative diseases. The roles of epigenetic changes like DNA methylation and histone acetylation in transcriptional ... -
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
(Brac University, 2019-05)Alzheimer’s disease is one of leading diseases which provokes different internal physiological conditions that ease deterioration of normal body mechanism among people over 60 years of age. The proper pathophysiology of ... -
Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
(Brac University, 2021-11)Tau protein is one of the keystones in the diagnosis of Alzheimer’s disease. The modern detection techniques have come up to visualize, track and assess tau pathology and have further contributed with information about tau ... -
A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
(BRAC University, 2018-08)Alzheimer’s disease (AD), a deadly neurodegenerative disease, which is considered as one of the top causes of death for people who are over 65 years of age. Up until now, no drug has been developed that can cure this disease ...
